A role for granulocyte and monocyte apheresis in the treatment of rheumatoid arthritis
N Kashiwagi, I Hirata, R Kasukawa - Therapeutic Apheresis, 1998 - Wiley Online Library
Rheumatoid arthritis (RA) is an inflammatory condition, the etiology of which is not well
understood. Recent reports indicate a major role of granulocytes in the pathogenesis of RA; …
understood. Recent reports indicate a major role of granulocytes in the pathogenesis of RA; …
Filtration leukapheresis for granulocyte transfusion therapy: clinical and laboratory studies
DJ Higby, JW Yates, ES Henderson… - New England journal of …, 1975 - Mass Medical Soc
To study the clinical efficacy of granulocytes obtained by filtration leukapheresis, patients
with clinically evident infection and granulocyte counts of< 500 per cubic millimeter were …
with clinically evident infection and granulocyte counts of< 500 per cubic millimeter were …
Joint fluid leukocytosis of patient with rheumatoid arthritis Computer analysis of possible explanative factors
B Norberg, A Bjelle, S Eriksson - Clinical rheumatology, 1983 - Springer
The relationship between joint fluid leukocytosis and some clinical and laboratory
parameters (disease duration, ESR, maximal titres of rheumatoid factor and of antinuclear …
parameters (disease duration, ESR, maximal titres of rheumatoid factor and of antinuclear …
Increased granulocyte collection with the blood cell separator and the addition of etiocholanolone and hydroxyethyl starch
KB McCredie, EJ Freireich, JP Hester, C Vallejos - Transfusion, 1974 - Wiley Online Library
A total of 201 leukaphereses have been performed on 73 donors to collect granulocytes for
transfusion to infected leukopenic recipients. The pretreatment of the donor with …
transfusion to infected leukopenic recipients. The pretreatment of the donor with …
Therapeutic cytapheresis for inflammatory bowel disease
K Sawada, T Shimoyama - Therapeutic Apheresis, 1998 - Wiley Online Library
Cytapheresis therapy has recently been investigated as a treatment for several diseases,
especially autoimmune related diseases such as rheumatoid arthritis, systemic lupus …
especially autoimmune related diseases such as rheumatoid arthritis, systemic lupus …
Treatment of inflammatory immunologic disease 1. Leukocytapheresis for inflammatory immunologic disease (tentative)
M Watanabe, D Kubota, M Nagahori, T Kanai - Internal Medicine, 2007 - jstage.jst.go.jp
Both inflammatory bowel diseases and collagen vascular diseases are chronic inflammatory
disorders, whose pathogeneses are considered to be associated with their underlying …
disorders, whose pathogeneses are considered to be associated with their underlying …
Leukapheresis: clinical experience and post-transfusion control
J McCullough - Supportive therapy in haematology, 1985 - Springer
The availability of platelet transfusion support to patients with bone marrow failure (such as
aplastic anemia, or malignancy undergoing chemotherapy), has reduced the incidence of …
aplastic anemia, or malignancy undergoing chemotherapy), has reduced the incidence of …
Granulocyte transfusions. Technical data, granulocyte function and results
R Medenica, P Maurice, A Cruchaud… - Schweizerische …, 1976 - europepmc.org
A new method called" repetitive filtration leukopheresis" is described for granulocyte
transfusion therapy. 23 patients received a total of 91 transfusions. All patients presented …
transfusion therapy. 23 patients received a total of 91 transfusions. All patients presented …
関節リウマチ・悪性関節リウマチに対するアフェレシス療法(< 特集> 血管炎症候群とアフェレシス)
日高利彦 - 日本アフェレシス学会雑誌, 2015 - cir.nii.ac.jp
抄録 We have many procedures of an apheresis therapy for rheumatoid arthritis (RA);
plasma exchange, double filtration plasmapheresis, cryofiltration plasmapheresis …
plasma exchange, double filtration plasmapheresis, cryofiltration plasmapheresis …
Two years serial lymphocytapheresis of progressive hyperleukocytosis in a patient with a non-Hodgkin's lymphoma.
B Heil, T Wüst, HR Lang, HP Beeser… - … Contributions to Infusion …, 1992 - europepmc.org
A patient with non-Hodgkin's lymphoma was treated by ambulant lymphocytapheresis once
a month over a period of 2 years and 8 months. The cytoreductive effect resulted in a …
a month over a period of 2 years and 8 months. The cytoreductive effect resulted in a …